NuCana (NCNA) Cash from Financing Activities (2017 - 2025)

NuCana (NCNA) reported Cash from Financing Activities of $9311.2 for Q4 2025, down 99.67% on a YoY basis from $2.8 million in Q4 2024, and down 99.95% sequentially from $20.6 million in Q3 2025.

NuCana (NCNA) Cash from Financing Activities (2017 - 2025) Analysis & Trends

NuCana (NCNA) has 9 years of Cash from Financing Activities data on file, last reported at $9311.2 in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 99.67% year-over-year to $9311.2; the trailing twelve-month figure through Dec 2025 stood at $29.5 million (up 178.93% YoY), and the FY2025 full-year result was $33.0 million, up 215.16% from the prior year.
  • Cash from Financing Activities eased to $9311.2 in Q4 2025, from $20.6 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $20.6 million in Q3 2025 to a low of -$103431.9 in Q2 2021.
  • A 5-year average of $1.7 million and a median of -$44807.7 in 2022 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities sank 268.52% in 2023 and soared 7394.38% in 2024, its largest moves.
  • Tracing NCNA's Cash from Financing Activities over 5 years: stood at -$99752.8 in 2021, then soared by 131.75% to $31669.1 in 2022, then plunged by 268.52% to -$53369.5 in 2023, then jumped by 5354.78% to $2.8 million in 2024, then slumped by 99.67% to $9311.2 in 2025.
  • Business Quant data shows NCNA's Cash from Financing Activities at $9311.2 in Q4 2025, $20.6 million in Q3 2025, and $2.8 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 15.71 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 9,311.16
Dec 31, 2025 9,311.16
Sep 30, 2025 20.56 Mn
Sep 30, 2025 20.56 Mn
Dec 31, 2024 2.80 Mn
Dec 31, 2024 2.80 Mn
Sep 30, 2024 6.08 Mn
Sep 30, 2024 6.08 Mn
Jun 30, 2024 -79,519.91
Jun 30, 2024 -79,519.91
Mar 31, 2024 1.76 Mn
Mar 31, 2024 1.76 Mn
Dec 31, 2023 -53,369.53
Dec 31, 2023 -53,369.53
Sep 30, 2023 81,067.83
Sep 30, 2023 81,067.83
Jun 30, 2023 -41,294.98
Jun 30, 2023 -41,294.98
Mar 31, 2023 -49,835.89
Mar 31, 2023 -49,835.89